A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China

NCT06512337 ·Status: ACTIVE_NOT_RECRUITING

The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis

NCT03927352 ·Status: UNKNOWN ·Phase: PHASE3

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

NCT01401452 ·Status: COMPLETED

A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis

NCT05547490 ·Status: COMPLETED

Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab

NCT03099083 ·Status: COMPLETED

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00237887 ·Status: COMPLETED ·Phase: PHASE3

A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China

NCT04894890 ·Status: COMPLETED

Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00338754 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis

NCT05120297 ·Status: COMPLETED ·Phase: PHASE3

Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00645814 ·Status: COMPLETED ·Phase: PHASE2

Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.

NCT04711902 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

NCT06109818 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

NCT05531682 ·Status: COMPLETED ·Phase: PHASE2

Apremilast in Palmo-Plantar Psoriasis

NCT02400749 ·Status: COMPLETED ·Phase: PHASE4

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

NCT00566722 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00646191 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis

NCT02016482 ·Status: COMPLETED ·Phase: PHASE3

Chinese Psoriasis Real World Evidence Research

NCT04465838 ·Status: RECRUITING

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

NCT06842199 ·Status: RECRUITING ·Phase: PHASE3

A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

NCT06672393 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

NCT01543204 ·Status: TERMINATED ·Phase: PHASE4

Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis

NCT07251998 ·Status: RECRUITING ·Phase: PHASE2

Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03316781 ·Status: COMPLETED ·Phase: PHASE3

Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis

NCT07190391 ·Status: NOT_YET_RECRUITING

Effect of Adalimumab Therapy on Psoriasis Patient

NCT05889338 ·Status: UNKNOWN ·Phase: NA